Inactive Instrument

NEW RAYNPV Stock Hong Kong S.E.

2908

BMG647461455

New Ray Medicine International Holding Ltd is an investment holding company principally engaged in the distribution and trading of pharmaceutical and the provision of marketing and promotion services. The Company operates its businesses through two segments. The Distribution and Trading of Pharmaceutical and Related Products segment is mainly engaged in the distribution and trading of drugs and chemical reagents for pharmaceutical. The Provision of Marketing and Promotion Services segment is mainly engaged in the provision of marketing and promotion services of drugs and chemical reagents for pharmaceutical. The Company mainly operates its businesses in the domestic market.

Employees

Sector

Drug Retailers

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	52.16M 6.65M 5.94M 5.49M 4.97M 9.3M 631M 9.46M 66.03M 26.14M 331M 24.96M 24.43M 1.04B	P/E 2024	-2.43x	P/E 2025	-2.3x
Enterprise Value	17.2M 2.19M 1.96M 1.81M 1.64M 3.07M 208M 3.12M 21.78M 8.62M 109M 8.23M 8.06M 344M	EV / Sales 2024	0.15x	EV / Sales 2025	0.16x
Free-Float	70.69%	Yield 2024 *	-	Yield 2025	-

12/10	New Ray Medicine International Holding Limited Announces Resignation of Chu Xueping as Executive Director, Effective October 12, 2026	CI
27/08	New Ray Medicine International Holding Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
26/03	New Ray Medicine International posts FY net loss attributable HK$20.1 million	RE
26/03	New Ray Medicine International Holding Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
24/12	New Ray Medicine Raises HK$7.4 Million from Share Placement; Shares Plunge 10%	MT
08/12	New Ray Medicine Eyes Over HK$7 Million from Share Placement; Shares Surge 16%	MT
06/12	New Ray Medicine International to place up to 33.4 million shares	RE
27/08/25	New Ray Medicine International Holding Limited Reports Earnings Results for the Half Year Ended June 30, 2025	CI
13/08/25	New Ray Medicine International says China New Rich enters cooperation agreement	RE
07/08/25	New Ray Medicine Unit Sells Jiangxi Rimag Shares for HK$12.8 Million; Shares Lose 3%	MT
07/08/25	New Ray Medicine International says unit disposes 801,000 Jiangxi Rimag shares for HK$12.8 million	RE

Manager	Title	Age	Since
Qiuqin Wang CEO	Chief Executive Officer	48	31/07/2020
Yat Sing Ng SEC	Corporate Secretary	-	11/07/2023

Director	Title	Age	Since
Chi Kin Leung BRD	Director/Board Member	76	26/09/2013
Sin Ming Li BRD	Director/Board Member	50	20/06/2017
Qiuqin Wang CHM	Chairman	48	15/05/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NEW RAYNPV	-.--%	+2.38%	-	-	6.65M
JD HEALTH INTERNATIONAL INC.	-1.00%	-2.49%	-39.84%	+10.43%	15.29B
RAIA DROGASIL S.A.	+10.52%	-1.36%	+5.65%	-21.56%	7.04B
MATSUKIYOCOCOKARA & CO.	-0.06%	+3.10%	-9.16%	+1.74%	6.58B
TSURUHA HOLDINGS INC.	+2.02%	+0.88%	-16.14%	+4.92%	6.44B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	+0.70%	-4.66%	-51.60%	-35.18%	5.91B
YIFENG PHARMACY CHAIN CO., LTD.	-1.13%	+1.12%	+0.60%	-3.85%	4.61B
COSMOS PHARMACEUTICAL CORPORATION	+0.41%	-1.67%	-14.82%	-14.74%	3.21B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-0.77%	-2.42%	-2.78%	-20.91%	3.1B
CLICKS GROUP LIMITED	-6.97%	-9.76%	-42.31%	-11.24%	3.02B
Average	+0.37%	-2.38%	-18.94%	-10.04%	6.13B
Weighted average by Cap.	+0.87%	-1.82%	-22.10%	-5.81%

NEW RAYNPV Stock Hong Kong S.E.

Stocks

2908

BMG647461455

Drug Retailers

Valuation: NEW RAYNPV

Latest news: NEW RAYNPV

Managers and Directors: NEW RAYNPV

Other Drug Retailers

Financials

Company Profile

	2024	2025
Net sales	93.94M 11.98M 10.7M 9.88M 8.96M 16.76M 1.14B 17.03M 119M 47.08M 596M 44.96M 44M 1.88B	130M 16.62M 14.85M 13.71M 12.43M 23.25M 1.58B 23.64M 165M 65.34M 827M 62.39M 61.06M 2.61B
Net income	-31.01M -3.95M -3.53M -3.26M -2.96M -5.53M -375M -5.62M -39.26M -15.54M -197M -14.84M -14.53M -620M	-20.07M -2.56M -2.29M -2.11M -1.91M -3.58M -243M -3.64M -25.4M -10.06M -127M -9.6M -9.4M -401M
Net Debt	-60.71M -7.74M -6.91M -6.39M -5.79M -10.83M -735M -11.01M -76.85M -30.42M -385M -29.05M -28.43M -1.21B	-34.96M -4.46M -3.98M -3.68M -3.33M -6.23M -423M -6.34M -44.25M -17.52M -222M -16.73M -16.37M -699M